I11220—Biostatistics

Contact:

Mentor: Hemant K. Tiwari, Ph.D. Statistical Genetics Department of Biostatistics Mailing address: RPHB 327 1530 3RD AVENUE S BIRMINGHAM AL 35294-0022 Telephone: (205) 934-4907 Fax: (205) 975-2541 E-mail: htiwari@uab.edu


Postdoctoral Positions Available

The Section on Statistical Genetics in the Department of Biostatistics at the University of Alabama at Birmingham is accepting applications from statistical and other scientists for postdoctoral positions in any aspect of Statistical Genomics from basic evolutionary biology to biomedical or agricultural applications. Several appointments, funded through the NIH T32 grant (T32HL072757) awarded by the National Heart Lung and Blood Institute (NHLBI), are anticipated. The funds from this grant may be used only for US Citizens or permanent residents. In very rare cases we are able to identify additional funds for the exceptional applicant who is neither a US Citizen or permanent resident, but this is a rarity. Starting dates are open and flexible. Appointments will be for two years, with possible extension for another year. Salary is commensurate with qualifications but in all cases equals or exceeds NIH post-doctoral stipends. 

The training program is designed for postdoctoral trainees with doctoral degrees and some prior training or expertise in the statistical, mathematical, computational, or biological sciences who seek training at the interface between statistical and molecular genetics.

Criteria for selection include demonstrated research ability in statistics or a relevant scientific discipline, interest and (to a lesser degree) experience in project areas, strength in computation and in verbal and written communication, and genuine commitment to methodological and cross-disciplinary research in quantitative genetics.

The University of Alabama at Birmingham is an equal opportunity employer. Women, minorities, and persons with disabilities are encouraged to apply.  Women, persons with disabilities, and members of underrepresented minority groups are particularly encouraged to apply.

The section on Statistical Genetics at UAB has at present 12 faculty members and 11 postdoctoral fellows. The Department of Biostatistics has a total of 24 faculty members. For more information on the Section on Statistical Genetics, please visit our Website athttp://www.ssg.uab.edu/.

Application should consist of a letter of interest containing addresses, telephone numbers and citizenship status; names of three references, a CV with publication record and/or thesis topic, and a one-page statement of interest. Please submit the application to:

Hemant Tiwari, Ph.D., Chair, Search Committee Interim Head, Section on Statistical Genetics Dept of Biostatistics William "Student" Sealy Gosset Associate Professor Director Biostatistics Pre-Doctoral NHLBI Training Program Associate Director Statistical Genetics Post-Doctoral NHLBI Training Program Ryals Public Health Bldg, 420D University of Alabama at Birmingham Birmingham, AL 35294  Phone: (205) 934-4907  Fax: (205) 975-2540  Email:htiwari@uab.edu

UAB News

  • Mixed-media, design and sculptural works by Department of Art and Art History students Rob Clifton, Alejandra Garbutt and Nathan Truitt will be on display Dec. 1-13.Rob Clifton: "Idealized Serpentine Forms," 2014; paper, newspaper, canvas, acrylic, wheat paste, cardboard, masonite, string, space & light; site-specific installation, dimensions variableWorks by three graduating students from the University of Alabama at Birmingham’s Department of Art and Art History will be on exhibition Dec. 1-13, in the College of Arts...

  • The manufacturer of a new medication for Rett syndrome studied at UAB is encouraged by the drug’s performance.A recently concluded study of an experimental drug for Rett syndrome showed promising results, according to the drug’s manufacturer, Neuren Pharmaceuticals of Melbourne, Australia. The University of Alabama at Birmingham was one of three study sites for the drug, known as NNZ-2566. Neuren announced Nov. 12 that the Phase II study had achieved its primary endpoint as two dose...